Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

Researchers at the University of Arizona Health Sciences have uncovered a promising new approach for treating prostate cancer ...

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined ...

Researchers at University of Arizona Cancer Center used a double-pronged approach to reduce tumor growth in tissue samples of ...

Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.

The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...

Here are key facts, risk factors, and life-saving screening recommendations for colorectal cancer prevention and treatment.

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, ...